Surveillance Program for Chronic Kidney Disease
(CKD Safety-Net Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The objective of this initiative is to develop and evaluate a risk-based, provincial public health screening program for chronic kidney disease (CKD) that provides proactive care for adults at high-risk of kidney failure who have not previously been referred to a nephrologist, through risk stratification, triage, education, and follow-up.
Overall, we aim to demonstrate that an integrated risk-based provincial public health screening program for CKD is feasible, and improves identification of high-risk individuals, subsequently creating a model of care that can be adopted by other jurisdictions.
Who Is on the Research Team?
Navdeep Tangri, MD, PhD
Principal Investigator
University of Manitoba
Are You a Good Fit for This Trial?
This trial is for adults in Manitoba with chronic kidney disease who are at high risk of kidney failure, but have not yet seen a kidney specialist. People already on dialysis, who've had a kidney transplant, or are receiving palliative care can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a letter describing their results and an invitation for a consult with a clinical assistant and a nephrologist
Follow-up
Participants are monitored for kidney failure, mortality, and other health outcomes using provincial administrative databases
What Are the Treatments Tested in This Trial?
Trial Overview
The study is testing whether sending educational letters and follow-up to high-risk CKD patients helps identify and manage their condition better. It uses screening and proactive outreach as part of a public health program.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Individuals randomized to the intervention group will receive a letter from MCHP. A follow-up reminder letter will be sent at 3 months in individuals that do not respond to the initial invitation. Individuals who respond to the letter by contacting the study team will be scheduled for an initial clinic appointment with a Clinical Assistant/Nephrologist, and will begin receiving routine clinical care thereafter, as per local clinical guidelines.
Individuals randomized to the control group will continue receiving usual care without any intervention from the study team. Their outcomes will be ascertained using de-identified administrative data. If the trial is successful, indivdiuals in the control group will be contacted for follow-up with a nephrologist in the same manner (i.e. through a mailout letter) as the intervention group was.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor
Can-SOLVE CKD Network
Collaborator
Seven Oaks Hospital Chronic Disease Innovation Centre
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.